ArticleJournal of the American Heart Association2024
Incidence, Risk Factors, and Outcomes Associated With Permanent Pacemaker Implantation Following Tricuspid Valve Surgery.
Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Incidence of Permanent Pacemaker Implantation Following Tricuspid Valve Surgeries: A Systematic Review and Meta-Analysis.Innovations (Philadelphia, Pa.)Pooled it
- Leadless Pacing for Delayed Heart Block After Transcatheter Tricupid Valve Replacement.JACC. Case reports · 2026Article
- Contemporary Surgical Tricuspid Valve Repair.Journal of clinical medicine · 2026Review
- Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery.Journal of the American Heart Association · 2026Article
- Acute and midterm outcomes of patients undergoing right-sided heart valve surgery for carcinoid heart valve disease.JTCVS techniques · 2026Article
- Observational
- Surgical and Transcatheter Tricuspid Valve Interventions: An Electrophysiology-Focused Review.Journal of cardiovascular development and disease · 2026Review
- 2025 ESC/EACTS valvular heart disease guidelines: practical updates on mitral and tricuspid regurgitation.European heart journal supplements : journal of the European Society of Cardiology · 2026Article
- Infective Endocarditis After Arrythmia Device Implantation in Cardiac Surgery Patients.Journal of the American Heart Association · 2026Article
- Paroxysmal atrioventricular block: A warning sign for permanent block after transcatheter tricuspid valve replacement.HeartRhythm case reports · 2026Article
- Concomitant Tricuspid Annuloplasty During Mitral Surgery: Becoming an Unpopular Practice?Annals of thoracic surgery short reports · 2025Article
- Managing Bradycardia in Patients After Transcatheter Tricuspid Valve Replacement.Structural heart : the journal of the Heart Team · 2025Review
- Cardiac implantable electronic devices in the setting of tricuspid valve intervention: Risks, options, extraction and future perspectives: A state-of-the-art review.Heart rhythm O2 · 2025Review
- Outcomes of isolated tricuspid replacement versus repair among older patients with tricuspid regurgitation in the United States.JTCVS open · 2025Article
- Comparison of Transcatheter Versus Surgical Tricuspid Repair Among Patients With Tricuspid Regurgitation: Two-Year Results.Circulation. Cardiovascular interventions · 2025Article
- Permanent pacing via coronary sinus after tricuspid valve replacement: Keep bipolar coronary sinus leads on hand!Indian pacing and electrophysiology journalArticle
- The 10 Commandments for Endoscopic Minimally Invasive Tricuspid Valve Repair.Innovations (Philadelphia, Pa.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundData regarding permanent pacemaker (PPM) implantation following tricuspid valve surgery (TVS) are limited. We sought to evaluate its incidence, risk factors, and outcomes. METHODS AND
resultsMedicare beneficiaries who underwent TVS from 2013 to 2020 were identified. Patients who underwent TVS for endocarditis were excluded. The primary exposure of interest was new PPM after TVS. Outcomes included all-cause mortality and readmission with endocarditis or heart failure on follow-up. Among the 13 294 patients who underwent TVS, 2518 (18.9%) required PPM placement. Risk factors included female sex (relative risk [RR], 1.26 [95% CI, 1.17-1.36],
conclusionsPPM implantation frequently occurs after TVS, notably in female patients and patients undergoing TV replacement. Although mortality is not increased, it is associated with higher rates of heart failure rehospitalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.